Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

Bullboard (TSX:MSL)

View:
Comment by smocheron Dec 23, 2016 7:55am

RE:James Hodgins

hes a little deluded about Merus, its in the penalty box
Post by retiredcfon Dec 23, 2016 7:03am

James Hodgins

You've got to give him credit for perseverance. As can be seen, it remains the 3rd largest holding in his fund. GLTA TOP PICKSMERUS LABS (MSL.TO)A former top pick that has been unfairly hit ...more  
Comment by Spidey2332on Dec 21, 2016 4:59pm

RE:Last Chance

spent the day loading up. I too think this is rock bottom. I am looking 2 years out now and I hope I am not in a ship of fools lol.
Comment by Kensin1953on Dec 21, 2016 12:07pm

RE:RE:RE:RE:RE:James Hodgins

No!  Just my futile attempt at being sarcastic.  I will check with my cat though. I'm all ears if you have some stocks that fit your criteria.  Sold ZEN, ROG, NXE too soon missed ...more  
Comment by Albanianon Dec 21, 2016 3:13am

RE:RE:RE:RE:James Hodgins

I hope your not being serious on MJ stocks ? Why would you pay insane valuations for coMpanys that have nothing for sales. This is the problem with Merus and a bunch of healthcare stocks few years ...more  
Comment by BillyBufford155on Dec 21, 2016 2:13am

RE:Valuation Attempt for MSL

Sorry all, on my last post, it should read: "...management seemed to NOT offer a clear strategy on how this company is going to get its debt level under control and start earning an actual EPS... ...more  
Post by BillyBufford155on Dec 21, 2016 2:07am

Valuation Attempt for MSL

This stock has really gotten beaten up. I know it was really hyped up when it was raising money (surprise, surprise...?). During the last earnings call, the management seemed to offer a clear strategy ...more  
Comment by Kensin1953on Dec 21, 2016 12:52am

RE:RE:RE:James Hodgins

Hard not to agree with you. Seems highly suspect.  What's the low $.50c  a few years back. I guess there has been no progress since then. No improvement in sales, no new agreements, no ...more  
Comment by Dojitrader15on Dec 20, 2016 11:39pm

RE:RE:James Hodgins

I honestly think this douche bag has a short position on each and every one of his top picks. There's just something about him, not sure why BNN even has him on anymore.
Post by Kensin1953on Dec 20, 2016 12:54pm

Tax Loss Selling

What's the last day in Canada?
Comment by kuatoliveson Dec 19, 2016 1:35pm

RE:James Hodgins

PHM, Concordia, Valeant, Merus, Nobilis..... these are the greatest hits of BNN "top picks" in the pharma space over the last couple of years. Do you really need any more evidence to stop ...more  
Post by lscfaon Dec 19, 2016 8:46am

Trading at < 3x cash flow

Cfps:        Q4 16...... $0.09        Q3 16........$0.07        Q2 16........$0.07        Q1 16........$0.08 ...more  
Post by retiredcfon Dec 19, 2016 8:02am

James Hodgins

Is scheduled to be on Market Call Tonight on Thursday. It will be interesting to get his take on things given that he recently made MSL his top pick in a Globe & Mail article, not to mention, when ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities